Cargando…

Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via Notch inhibition by competitively binding to Jag1

Microglia were considered as immune cells in inflammation until their angiogenic role was widely understood. Although the pro-inflammatory role of microglia in retinal angiogenesis has been explored, little is known about its role in pro-angiogenesis and the microglia–endothelia interaction. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zi-Yi, Chang, Tian-Fang, Lin, Zhi-Bin, Jing, Yu-Tong, Wen, Li-Shi, Niu, Ya-Li, Bai, Qian, Guo, Chang-Mei, Sun, Jia-Xing, Wang, Yu-Sheng, Dou, Guo-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300109/
https://www.ncbi.nlm.nih.gov/pubmed/37369647
http://dx.doi.org/10.1038/s41419-023-05897-8
Descripción
Sumario:Microglia were considered as immune cells in inflammation until their angiogenic role was widely understood. Although the pro-inflammatory role of microglia in retinal angiogenesis has been explored, little is known about its role in pro-angiogenesis and the microglia–endothelia interaction. Here, we report that galectin-3 (Gal3) released by activated microglia functions as a communicator between microglia and endothelia and competitively binds to Jag1, thus inhibiting the Notch signaling pathway and enhancing endothelial angiogenic metabolism to promote angiogenesis. These results suggest that Gal3 may be a novel and effective target in the treatment of retinal angiogenesis.